NCOA3 and cancer: In addition, in the absence of estrogen, SRC3 binds to the Y537S mutant with an affinity that is higher than when it binds to the D538G mutant. These differences between the two mutations may have clinical implications, as recent data suggests that they may be associated with different outcomes in cancer patients (Chandarlapaty, 2015).